PHIN-214 Subcutaneous injection Clinical Trials

1 actively recruiting trial across 1 location

No change since May 2026

Also known as: Terlipressin derivative

Pipeline

Phase 1: 1

Top Sponsors

PharmaIN1

Indications

Ascites Hepatic1
Liver Disease1
Liver Fibrosis1
Cirrhosis, Liver1

Chandler, Arizona1 trial

Single and Multiple Dose Escalation of PHIN-214 in Child-Pugh A and B Liver Cirrhotics

Arizona Liver Health

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.